Aretemether & Lumefantrine Tablets 20 mg + 120 mg Manufacturer

Aretemether & Lumefantrine Tablets 20 mg + 120 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Aretemether & Lumefantrine Tablets 20 mg + 120 mg Manufacturer product packaging

Aretemether & Lumefantrine Tablets 20 mg + 120 mg | Manufacturer

Product image for Aretemether & Lumefantrine Tablets 20 mg + 120 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameAretemether & Lumefantrine
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP / BP
Product TypeTablet
CategoryAntimalarial drugs
SubcategoryAntimalarial drugs
Active IngredientAretemether & Lumefantrine
Strength20 mg + 120 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntimalarial drugs

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Aretemether & Lumefantrine Tablets 20 mg + 120 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Acute oral treatment of uncomplicated malaria caused by Plasmodium falciparum. 2. Treatment of mixed Plasmodium infections and chloroquine-resistant malaria strains in endemic regions.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Aretemether & Lumefantrine Tablets 20 mg + 120 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameAretemether & Lumefantrine
CompositionAretemether & Lumefantrine
Strength20 mg + 120 mg
CategoryAntimalarial drugs
PharmacopoeiaIP / BP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Aretemether & Lumefantrine Tablets 20 mg + 120 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Aretemether & Lumefantrine Tablets 20 mg + 120 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Aretemether & Lumefantrine Tablets 20 mg + 120 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally with meals or full-fat milk to maximize therapeutic systemic absorption. Take exactly as prescribed for the complete 3-day treatment schedule without missing any doses.
Side EffectsCommon: Headache, dizziness, anorexia, nausea, abdominal discomfort, fatigue. Uncommon: Pruritus, sleep disturbances, palpitation, arthralgia, vomiting. Rare: Cardiac conduction abnormalities (QTc prolongation), hematologic cytopenias.
Warnings and PrecautionsNot for Prophylaxis: Indicated solely for curative therapy of acute uncomplicated malaria. Severe Malaria Alert: If signs of complicated or cerebral malaria emerge, transfer immediately to parenteral therapy. Cardiac Monitoring: Caution in patients with preexisting cardiac arrhythmias.
Contraindications1. Known hypersensitivity to Aretemether & Lumefantrine or related antimalarial compounds.
2. Severe malaria presenting with coma, severe acidosis, or pulmonary edema.
3. Congenital prolonged QT syndrome or clinically significant cardiac arrhythmias.
Drug Interactions1. Strong CYP3A4 Inducers/Inhibitors: Alter systemic exposure of active antimalarial moieties.
2. QTc-Prolonging Drugs (Antiarrhythmics, Macrolides): Heightened risk of ventricular dysrhythmias.
3. Antiretrovirals: Variable pharmacokinetic interactions; monitor clinical parasitic response.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Aretemether & Lumefantrine Tablets 20 mg + 120 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Aretemether & Lumefantrine Tablets 20 mg + 120 mg?The source specification is IP / BP; confirm the required standard before contracting.
What quality tests are applicable for Aretemether & Lumefantrine Tablets 20 mg + 120 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Aretemether & Lumefantrine Tablets 20 mg + 120 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Aretemether & Lumefantrine Tablets 20 mg + 120 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Tags

Aretemether & Lumefantrine Tablets 20 mg + 120 mg ManufacturerAretemether & Lumefantrine 20 mg + 120 mgContract ManufacturingOEM & Quality ControlHealthy Life Pharma Pvt. Ltd.

Product Hashtags

#Aretemether#Manufacturer#PharmaB2B

Related Products

Latest Posts